home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Cutting Cholesterol With RNAi

  November, 23 2004 8:33
your information resource in human molecular genetics
A technique called 'RNA interference' (RNAi) holds tremendous promise as a means to cure ailments by shutting off disease-causing genes; however, it has been difficult to make the technique work in the cells that need it most. In the 11 Nov 2004 issue of Nature (Vol. 432, No. 7014, pp. 173-178), Hans-Peter Vornlocher and colleagues report a simple and ground-breaking new way to use RNAi to cut cholesterol levels in mice. The technique reveals a practical way in which RNAi might be used to treat a broad range of ailments - including coronary artery disease - that affect an animal's body.

The new work shows how RNAi could be used to treat a much broader range of diseases than is currently possible. "It remains to be seen whether [this] approach can be used to silence other disease-related genes in animal models. If so, it should revolutionise the use of RNAi", writes John Rossi in an accompanying News & Views article.


Hans-Peter Vornlocher (Alnylam Pharmaceuticals, Kulmbach, Germany)
E-mail: hpvornlocher@alnylam.de

John Rossi (Beckman Research Institute of the City of Hope, Duarte, CA, USA)
Tel: +1 626 301 8360, E-mail: jrossi@coh.org

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.